Scientific Online Resource System

International Bulletin of Otorhinolaryngology

Clinical approach to tympanostomy tube otorrhea in children

Iglika Stancheva, Venera Dobriyanova

Abstract

Tympanostomy tube otorrhea in children is drainage from the middle ear through the tube. Persistent or recurrent episodes require reassessment of the infection and the factors that may sustain discharge. This narrative review examines the role of culture and antimicrobial susceptibility testing in clinical decision-making. Topical antibiotics are the first choice for acute uncomplicated episodes. Culture is particularly useful when drainage persists despite adequate topical treatment, in recurrent episodes or a complicated course. It may identify an organism against which empirical treatment is inactive, but the laboratory result must be interpreted alongside otoscopic findings, delivery of the drug to the site of infection and the observed response. Systemic susceptibility breakpoints are not validated predictors of the response to ear drops, and a high nominal drug concentration does not guarantee clinical success. Tube obstruction, granulation tissue and fungal infection may also explain persistent drainage. Microbiological testing should guide a clinically justified treatment decision that considers both antimicrobial activity and middle-ear safety.


Keywords

otorrhea; children; tympanostomy tubes; culture; antimicrobial susceptibility; topical treatment

Full Text


References

Rosenfeld RM, Tunkel DE, Schwartz SR, et al. Clinical Practice Guideline: Tympanostomy Tubes in Children (Update). Otolaryngol Head Neck Surg. 2022;166(1_suppl):S1–S55. doi:10.1177/01945998211065662

NICE. Otitis media with effusion in under 12s. NG233. 2023. Recommendations 1.6.9–1.6.10. Official source

Zorginstituut Nederland. Farmacotherapeutisch Kompas. Otitis media acuta. Algorithm for tympanostomy tube otorrhea. Official source

Dohar J, Giles W, Roland P, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2006;118(3):e561–e569. doi:10.1542/peds.2005-2033

Roland PS, Kreisler LS, Reese B, et al. Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Pediatrics. 2004;113(1 Pt 1):e40–e46. doi:10.1542/peds.113.1.e40

Roland PS, Anon JB, Moe RD, et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope. 2003;113(12):2116–2122. doi:10.1097/00005537-200312000-00011

van Dongen TMA, Venekamp RP, Wensing AMJ, Bogaert D, Sanders EAM, Schilder AGM. Acute otorrhea in children with tympanostomy tubes: prevalence of bacteria and viruses in the post-pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 2015;34(4):355–360. doi:10.1097/INF.0000000000000595

Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43(11):1417–1422. doi:10.1086/509332

DailyMed. Ciprofloxacin and dexamethasone otic suspension. Prescribing information. Sections 2.2, 5.2, 5.3. Official source

EUCAST. Guidance document on topical agents. Version 4. 2022. Linked from: Breakpoint tables for interpretation of MICs and zone diameters, version 16.1, 2026. Official source

Walker DD, David MZ, Catalano D, Daum R, Gluth MB. In vitro susceptibility of ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus to ototopical therapy. Otolaryngol Head Neck Surg. 2018;158(5):923–929. doi:10.1177/0194599818762382

Cheng J, Javia L. Methicillin-resistant Staphylococcus aureus (MRSA) pediatric tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2012;76(12):1795–1798. doi:10.1016/j.ijporl.2012.09.003

Noonan KY, Kim SY, Wong LY, Martin IW, Schwartzman JD, Saunders JE. Treatment of ciprofloxacin-resistant ear infections. Otol Neurotol. 2018;39(9):e837–e842. doi:10.1097/MAO.0000000000001966

Ramanathan D, Postevka E, Raol N, Appachi S, Hopkins B, Anne S. Refractory tympanostomy tube otorrhea: outcomes with otowick placement. Int J Pediatr Otorhinolaryngol. 2023;169:111554. doi:10.1016/j.ijporl.2023.111554

Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005;69(11):1503–1508. doi:10.1016/j.ijporl.2005.04.012

Idicula WK, Jurcisek JA, Cass ND, et al. Identification of biofilms in post-tympanostomy tube otorrhea. Laryngoscope. 2016;126(8):1946–1951. doi:10.1002/lary.25826

Yankey H, Isaacson G. Efficacy of topical 2% mupirocin ointment for treatment of tympanostomy tube otorrhea caused by community-acquired methicillin resistant Staphylococcus aureus. Int J Pediatr Otorhinolaryngol. 2018;109:36–39. doi:10.1016/j.ijporl.2018.03.024

American Academy of Otolaryngology–Head and Neck Surgery. AAO12: Tympanostomy tubes: topical ear drop monotherapy for acute otorrhea. Quality measure specification. 2026. https://www.entnet.org/wp-content/uploads/2025/12/2026_AAO12_12192025.pdf [accessed 12 October 2026].




DOI: http://dx.doi.org/10.14748/orl.v22i3.10928

Refbacks

Font Size


|